Assignee
PROCHON BIOTECH LTD
IL·11 granted patents·5 pending applications·1,736 citations·filing 2003–2017
Top patents by PatentIndex Score
16 records- 0197US7009039B2Plasma protein matrices and methods for their preparationPROCHON BIOTECH LTD·Filed 2004·Granted Mar 7, 2006·1.4k cites·53 claims
- 0294US7276481B2Method and composition for treatment of skeletal dysplasiasPROCHON BIOTECH LTD·Filed 2003·Granted Oct 2, 2007·91 cites·30 claims
- 0393US7563769B2FGF variants and methods for use thereofPROCHON BIOTECH LTD·Filed 2004·Granted Jul 21, 2009·54 cites·35 claims
- 0493US7288406B2Active variants of FGF with improved specificityPROCHON BIOTECH LTD·Filed 2003·Granted Oct 30, 2007·109 cites·22 claims
- 0590US7335508B2Porous plasma protein matrices and methods for preparation thereofPROCHON BIOTECH LTD·Filed 2004·Granted Feb 26, 2008·46 cites·35 claims
- 0688US8916522B2FGF-9 variants and methods of use thereofPROCHON BIOTECH LTD·Filed 2013·Granted Dec 23, 2014·4 cites·5 claims
- 0785US7714107B2Freeze-dried fibrin matrices and methods for preparation thereofPROCHON BIOTECH LTD·Filed 2005·Granted May 11, 2010·6 cites·16 claims
- 0879US7887831B2Bone enhancing compositePROCHON BIOTECH LTD·Filed 2003·Granted Feb 15, 2011·8 cites·32 claims
- 0970US9487568B2FGF-2 variants and methods of use thereofPROCHON BIOTECH LTD·Filed 2014·Granted Nov 8, 2016·0 cites·19 claims
- 1069US2008194682A1Method and composition for treatment of skeletal dysplasiasPROCHON BIOTECH LTD·Filed 2007·Application pending·0 cites
- 1162US2017095533A1FGF-9 Variants and Methods of Use ThereofPROCHON BIOTECH LTD·Filed 2016·Application pending·0 cites
- 1255US2015164486A1Method and apparatus for restoring articular cartilagePROCHON BIOTECH LTD·Filed 2014·Application pending·0 cites
- 1353US2017296156A1Method and apparatus for restoring articular cartilagePROCHON BIOTECH LTD·Filed 2017·Application pending·0 cites
- 1452US8940888B2Hydrazido derivatives of hyaluronic acidPROCHON BIOTECH LTD·Filed 2013·Granted Jan 27, 2015·0 cites·14 claims
- 1550US2018127475A1Fgf-2 variants having n-terminal deletions and increased receptor selectivity and uses thereofPROCHON BIOTECH LTD·Filed 2017·Application pending·0 cites
- 1647US9862753B2FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereofPROCHON BIOTECH LTD·Filed 2015·Granted Jan 9, 2018·0 cites·7 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →